G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.7 CNY 3.16% Market Closed
Market Cap: 5.6B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

Income Statement

Earnings Waterfall
GemPharmatech Co Ltd

Revenue
666.7m CNY
Cost of Revenue
-232.2m CNY
Gross Profit
434.5m CNY
Operating Expenses
-302.1m CNY
Operating Income
132.4m CNY
Other Expenses
25.3m CNY
Net Income
157.7m CNY

Income Statement
GemPharmatech Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
394
N/A
433
+10%
466
+8%
500
+7%
517
+3%
541
+5%
562
+4%
585
+4%
622
+6%
639
+3%
667
+4%
Gross Profit
Cost of Revenue
(101)
(109)
(119)
(136)
(150)
(166)
(181)
(187)
(203)
(214)
(232)
Gross Profit
293
N/A
324
+11%
347
+7%
364
+5%
366
+1%
375
+2%
381
+2%
398
+4%
419
+5%
424
+1%
435
+2%
Operating Income
Operating Expenses
(163)
(180)
(183)
(202)
(204)
(232)
(246)
(267)
(264)
(296)
(302)
Selling, General & Administrative
(143)
(158)
(167)
(175)
(183)
(186)
(194)
(199)
(212)
(218)
(225)
Research & Development
(55)
(62)
(70)
(79)
(83)
(89)
(95)
(97)
(94)
(95)
(87)
Depreciation & Amortization
0
0
0
0
0
0
0
0
(2)
0
0
Other Operating Expenses
35
40
54
51
62
43
43
29
44
17
10
Operating Income
130
N/A
144
+11%
163
+14%
162
-1%
162
+0%
143
-12%
135
-5%
131
-3%
155
+18%
129
-17%
132
+3%
Pre-Tax Income
Interest Income Expense
14
13
21
29
25
29
27
21
29
31
27
Non-Reccuring Items
0
(0)
(0)
(0)
(13)
0
(0)
(0)
(20)
0
0
Total Other Income
0
0
0
(0)
(0)
(0)
(0)
(0)
(2)
(2)
(2)
Pre-Tax Income
143
N/A
157
+10%
184
+17%
190
+3%
174
-9%
171
-1%
162
-5%
152
-6%
161
+6%
157
-3%
157
+0%
Net Income
Tax Provision
(18)
(20)
(24)
(23)
(9)
(6)
(1)
2
(2)
0
1
Income from Continuing Operations
125
137
160
168
165
165
161
154
159
157
158
Net Income (Common)
125
N/A
137
+10%
160
+17%
168
+5%
165
-2%
165
+0%
161
-3%
154
-4%
159
+3%
157
-1%
158
+0%
EPS (Diluted)
0.3
N/A
0.33
+10%
0.39
+18%
0.41
+5%
0.4
-2%
0.4
N/A
0.39
-3%
0.38
-3%
0.39
+3%
0.38
-3%
0.39
+3%

See Also

Discover More